Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/7864
DC FieldValueLanguage
dc.contributor.authorMakazlieva, Tanjaen_US
dc.contributor.authorVaskova, Olivijaen_US
dc.contributor.authorTripunoski, Tonien_US
dc.contributor.authorMajstorov, Venjaminen_US
dc.date.accessioned2020-04-29T09:34:12Z-
dc.date.available2020-04-29T09:34:12Z-
dc.date.issued2017-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/7864-
dc.description.abstractEpidemiological data indicates that thyroid carcinoma (TC) is the most frequent endocrinological tumors, participating with around 1% from all malignomas. Because of lack of published papers related to the epidemiological data for TC in the last two decades in our country especially after the introduction of corrected Iodine prophylaxis program, with new higher Iodine supplementation in 1999, there is a need for publishing real scientific view of the epidemiological situations. The aim of the study was to present epidemiological data on incidence and prevalence rate of TC in R Macedonia for the period 1999-2010. Materials and methods: A retrospective analysis of medical data from all diagnosed and treated TC at the Institute of Pathophysiology and Nuclear Medicine during the period 1999-2010 was performed. The Institute is the only Center performing treatment of TC with 131I, therefore the registered epidemiological data are representative for the country. Statistical State Office data from the census in 1994 and 2002 were used to calculate annual incidence and prevalence rate as well as geographical and ethnic country distribution of TC. Results: During 12-year period, a total of 204 TC cases were registered, with prevalence rate of 10.15/105. The highest incidence rate was detected in 2000 (1.18/105) followed by reduction in 2003 (0,49/105). Annual incidence rate showed continuously higher incidence rate in the period 2006-2010 with average incidence rate of 0.98/105. Results indicate quite similar incidence rate among the three ethnic groups while the regional distribution indicates the highest prevalence in Skopje region, East and Northeast region than Southwest region. The lowest prevalence rate was registered in Polog, Southeast and Pelagonia region. Conclusions: According to the analyzed data from the diagnosed patients with TC during the period 1999 – 2010, there is increase in the incidence and prevalence rate, but however compared with the literature is still very low. Major differences in morbidity rate concerning the ethnic distribution were not found. Related to the geographical distribution of TC in eight regions, the highest prevalence rate was found in northern and eastern parts, while the lowest in western territories. Further analyzes are needed to compare it with the previous epidemiological data in the country, as well as an analysis for possible environmental effects for the low incidence rate, compared to those from literature.en_US
dc.language.isoenen_US
dc.relation.ispartofАрхиви на јавното здравјеen_US
dc.subjectthyroid carcinoma,en_US
dc.subjectepidemiology,en_US
dc.subjectincidence rate,en_US
dc.subjectprevalence rate,en_US
dc.subjectmortalityen_US
dc.titleИнциденција и преваленција на тироиден карцином во Република Македонија (1999-2010)en_US
dc.title.alternativeIncidence and prevalence of thyroid carcinoma in Republic of Macedonia (1999-2010)en_US
dc.typeArticleen_US
dc.identifier.volume9-
dc.identifier.issue1-
dc.identifier.fpage66-
item.fulltextWith Fulltext-
item.grantfulltextopen-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Files in This Item:
File Description SizeFormat 
1259-##default.genres.article##-4168-2-10-20171118.pdfArticle656.03 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

48
checked on Aug 14, 2024

Download(s)

6
checked on Aug 14, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.